When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure

Circulation. 2012 Jun 12;125(23):2948-55. doi: 10.1161/CIRCULATIONAHA.112.097337.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Carbazoles / therapeutic use*
  • Cardiotonic Agents / therapeutic use
  • Carvedilol
  • Diuretics / therapeutic use
  • Drug Therapy, Combination
  • Evidence-Based Medicine / methods
  • Furosemide / therapeutic use
  • Heart Failure / drug therapy*
  • Heart Failure / surgery*
  • Heart Transplantation
  • Heart-Assist Devices*
  • Humans
  • Lisinopril / therapeutic use*
  • Male
  • Middle Aged
  • Milrinone / therapeutic use*
  • Propanolamines / therapeutic use*
  • Severity of Illness Index
  • Spironolactone / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Carbazoles
  • Cardiotonic Agents
  • Diuretics
  • Propanolamines
  • Carvedilol
  • Spironolactone
  • Furosemide
  • Lisinopril
  • Milrinone